Concurrent chemoimmunotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status?
Pejcic
I
I
Clinic of Oncology, University Clinical Centre Nis, Nis, Serbia. ivicapejcic@gmail.com
Vrbic
S
S
Filipovic
S
S
Scekic
M
M
Petkovic
I
I
Pejcic
Lj
Lj